Challenge of Epidemiology: Issues and Selected Readings
Description:
"A great anthology. . . Discussions by the compilers are valuable."-Annals of Internal Medicine
"By publishing this book the Pan American Health Organization has done a big favor to those of us with an interest in the key events which have contributed to the development of epidemiology."-The Lancet
Edited by four eminent epidemiologists, this book consolidates, for the first time, a core of landmark articles on the evolution, scope and limitations, uses, and prospects of epidemiology. An outstanding feature of the book is the inclusion of the editors' assessments of the realm of epidemiology, where it is and where it should be going. It represents a useful tool for both students and practicing professionals and provides a much-needed frame of reference for reorienting the practice of epidemiology.
The book is a collection of 91 articles, grouped in five sections. The first two sections deal with the historical evolution of the discipline and sections 3 and 4 address the application of epidemiology. Finally, section 5 offers the editors views on epidemiology's future.
Best prices to buy, sell, or rent ISBN 9789275115053
Frequently Asked Questions about Challenge of Epidemiology: Issues and Selected Readings
The price for the book starts from $30.87 on Amazon and is available from 3 sellers at the moment.
If you’re interested in selling back the Challenge of Epidemiology: Issues and Selected Readings book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Challenge of Epidemiology: Issues and Selected Readings book, the best buyback offer comes from and is $ for the book in good condition.
The Challenge of Epidemiology: Issues and Selected Readings book is in very low demand now as the rank for the book is 6,289,379 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.